Antiparasitics in Animal Health: Quo Vadis?

Area of Science:

• Veterinary medicine
• Parasitology
• Animal health market analysis

Background:

• Antiparasitics are a major segment of the animal health market, but innovation has been slow.
• The isoxazoline class represents a recent success, though its full potential is untapped.
• Parasitic resistance is a significant challenge, creating demand for new solutions.

Purpose of the Study:

• To highlight the market need for novel antiparasitic agents.
• To discuss the potential of isoxazolines and the necessity for resistance-breaking therapies.
• To explore future directions in antiparasitic interventions, including vaccines and sustainable options.

Main Methods:

• Market share analysis of antiparasitic drugs.
• Review of recent advancements in antiparasitic research and development.
• Identification of emerging trends and needs in parasitic disease control.

Main Results:

• Antiparasitics constitute 23% of the animal health market.
• Few novel antiparasitic agents have been introduced recently, with isoxazolines being a notable exception.
• Widespread resistance necessitates the development of new antiparasitic strategies.

Conclusions:

• There is a clear market demand for novel antiparasitics that overcome existing resistance.
• Investment in new modalities like parasitic vaccines and environmentally friendly interventions is timely and crucial.
• Further exploration of isoxazoline potential and development of next-generation antiparasitics are warranted.